InVivo Therapeutics Holdings Corp. (NVIV) today announced appointment of Thomas R. Ulich, MD as Chief Scientific Officer, effective February 24, 2014.
Dr. Ulich previously served as Executive Vice-President of Research and Development of ConjuChem Biotechnologies from 2006 - 2010. Prior to that, he served as Senior Vice-President of Research and Development for Alnylam Pharmaceuticals from 2003-2004.
Help employers find you! Check out all the jobs and post your resume.
